W1, a Novel Oral Antiplatelet Agent With Less Resistance Than Clopidogrel-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

W1, a Novel Oral Antiplatelet Agent With Less Resistance Than Clopidogrel

Published:2017-02 Issue:2 Volume:69 Page:110-117
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Ge Pengxin,Du Li,Han Chunguang,Li Hui,Feng Yanguo,Han Jie,Wang Zhen,Xiong Liangzhong,Yuan Meiru,Liu Yongxue

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference32 articles.

1. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee;Antman;Circulation,2008

2. Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents;Trenk;J Am Coll Cardiol.,2008

3. A possible mechanism for the differences in efficiency and variability of active metabolite formation from thienopyridine antiplatelet agents, prasugrel and clopidogrel;Hagihara;Drug Metab Dispos.,2009

4. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite;Kazui;Drug Metab Dispos.,2010

5. Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently;Farid;Clin Pharmacol Ther.,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vicagrel enhances aspirin-induced inhibition of both platelet aggregation and thrombus formation in rodents due to its decreased metabolic inactivation;Biomedicine & Pharmacotherapy;2019-07

2. An Update on Novel Antiplatelets in Vascular Patients;Current Pharmaceutical Design;2019-02-27

3. Aspirin Attenuates the Bioactivation of and Platelet Response to Vicagrel in Mice;Journal of Cardiovascular Pharmacology;2018-11

4. Overcoming Clopidogrel Resistance: Three Promising Novel Antiplatelet Drugs Developed in China;Journal of Cardiovascular Pharmacology;2017-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3